How many patents does
Ucb Pharma have?
patents
3,990
families
406
granted
1,053
applications
2,937
US
677
EP
443
CN
250
WO
239
JP
203
GB
152
KR
99
RoW
1,927
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Ucb Pharma
Top ten assignees appearing on patents
2009 - 2018
| ucb pharma | 2324 |
| ucb biopharma | 696 |
| schwarz pharma | 191 |
| amgen | 113 |
| lts lohmann therapie-systeme | 85 |
| ucb | 41 |
| biogen idec ma | 30 |
| celltech r & d | 28 |
| sanol arznei schwarz | 23 |
| ucb farchim | 22 |
2009
| ucb pharma | 206 |
| schwarz pharma | 85 |
| medeva | 22 |
| celltech r & d | 14 |
| sanol arznei schwarz | 11 |
| ucb farchim | 11 |
| ucb | 6 |
| biogen idec ma | 5 |
| lts lohmann therapie-systeme | 5 |
| amgen | 5 |
2018
| ucb biopharma | 154 |
| ucb pharma | 66 |
| lts lohmann therapie-systeme | 16 |
| amgen | 4 |
| biogen ma | 2 |
| ucb farchim | 1 |
| 1) eveon; 2) ucb biopharma | 1 |
| schwarz pharma | 1 |
| darwin discovery | 1 |
| ucb | 1 |
Ucb Pharma
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| sclerostin binding agents | 121 | 2005 |
| pharmaceutical composition with synergistic anticonvulsant effect | 68 | 2006 |
| prolonged release formulations comprising an 2-oxo-1-pyrrolidine derivate | 57 | 2008 |
| antibody molecules having specificity for human tumor necrosis factor alpha, and use the… 🛈 | 53 | 2000 |
| auto-injector | 53 | 2011 |
| systems for administering medication for rheumatoid arthritis patients | 49 | 2008 |
| antibody molecules which bind il-17a and il-17f | 49 | 2011 |
| 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses | 45 | 2000 |
| binding proteins, including antibodies, antibody derivatives and antibody fragments, tha… 🛈 | 43 | 2007 |
| antibodies specific for human cd22 and their therapeutic and diagnostic uses | 42 | 2002 |